Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma

NCT06955169 is registered in ClinicalTrials.gov with RTOG Foundation, Inc. as lead sponsor.

NCT NCT06955169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06955169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma
Lead sponsor
RTOG Foundation, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
August 24, 2025
Completion date
August 31, 2030
Enrollment
130 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial meningioma